Showing 1,261 - 1,280 results of 3,081 for search '"Stem cell', query time: 0.10s Refine Results
  1. 1261

    CD4+CD25highCD127low Regulatory T Cells in Peripheral Blood Are Not an Independent Factor for Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation by Jolanta B. Perz, Selma Gürel, Stefan O. Schonland, Ute Hegenbart, Anthony D. Ho, Peter Dreger

    Published 2012-01-01
    “…The therapeutic efficacy of allogeneic hemopoietic stem cell transplantation (HSCT) largely relies on the graft-versus-leukemia (GVL) effect. …”
    Get full text
    Article
  2. 1262
  3. 1263
  4. 1264
  5. 1265

    Long-term survival and clinical implications of allogeneic stem cell transplantation in relapse/refractory lymphoma: A 20-year Singapore experience by Wei Sheng Joshua Loke, Jean Rachel Catapia, Chay Lee Low, Francesca Lim, Jeffrey Quek, Hein Than, Yeow Tee Goh, Yeh Ching Linn, Colin Phipps Diong, Aloysius Ho, William Hwang, Chung Cheng Jordan Hwang, Aditi Ghosh, Liang Pui Koh, Lip Koon Tan, Joanne Lee, Li Mei Michelle Poon, Cheng Kiat Lawrence Ng

    Published 2025-01-01
    “… Introduction: Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is a curative option for relapse/refractory (R/R) lymphomas that have failed autologous transplantation or for high-risk lymphomas in the upfront setting. …”
    Get full text
    Article
  6. 1266

    Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement by Stephan Zaenker, Stefan Schweyer, Justin Hasenkamp, Lorenz Truemper, Gerald Wulf

    Published 2011-01-01
    “…At year six after transplantation, the patient experienced disease progression by meningeosis leukaemia to which she succumbed despite intrathecal chemotherapy. Following allogeneic stem cell transplantation, awareness for atypical manifestations of granulocytic sarcoma appears prudent, the cellular immunotherapy should aim at immunological disease control.…”
    Get full text
    Article
  7. 1267

    Tumor Necrosis Factor Receptor 1 Is Required for Human Umbilical Cord–Derived Mesenchymal Stem Cell–Mediated Rheumatoid Arthritis Therapy by Guangyang Liu, Herui Wang, Chenliang Zhang, Xin Li, Yi Mi, Yaoyao Chen, Liqiang Xu, Li Miao, Haomiao Long, Yongjun Liu

    Published 2025-01-01
    “…Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) have shown potential in alleviating the symptoms of RA. …”
    Get full text
    Article
  8. 1268
  9. 1269
  10. 1270
  11. 1271
  12. 1272
  13. 1273

    Renal Ischemia-Reperfusion Injury in a Diabetic Monkey Model and Therapeutic Testing of Human Bone Marrow-Derived Mesenchymal Stem Cells by Kyo Won Lee, Tae Min Kim, Kyeong Sik Kim, Seunghwan Lee, Junhun Cho, Jae Berm Park, Ghee Young Kwon, Sung Joo Kim

    Published 2018-01-01
    “…We also investigated whether human bone marrow-derived mesenchymal stem cells (hBM-MSCs) infused via the renal artery could ameliorate renal IRI in DM monkeys. …”
    Get full text
    Article
  14. 1274
  15. 1275
  16. 1276
  17. 1277
  18. 1278

    TC2N maintains stem cell-like characteristics to accelerate lung carcinogenesis by blockade of dual specificity protein phosphatase 3 by Jing Gu, Yang-fan Lv, Ji-ying Xia, Fu-hai Bai, Ji Gong, Guang-qiang Pan, Bo Liu, Lu Huang, Qiao-nan Guo, Xiang-lin Hao

    Published 2025-01-01
    “…The protein levels of TC2N and stem cell markers in cell lines and tissue specimens were monitored by WB and immunohistochemistry. …”
    Get full text
    Article
  19. 1279
  20. 1280